Lexeo Therapeutics
Sr. Director, Corporate Strategy & New Product Planning
This range is provided by Lexeo Therapeutics. Your actual pay will be based on your skills and experience — talk with your recruiter to learn more.
Base pay range $220,000.00/yr - $275,000.00/yr
The Senior Director of Corporate Strategy & New Product Planning will play an integral role in bringing our groundbreaking AAV gene therapies to patients with genetic cardiomyopathies. In this high-impact role, the incumbent will build Lexeo’s launch planning function from the ground up, shaping brand strategy, market development, and launch readiness for first-in-class therapies poised to transform care in cardiac genetic diseases with high unmet need. You’ll combine strategic vision with hands‑on execution, crafting compelling scientific narratives, driving disease awareness, and preparing providers, patients, and payers for a new era in gene therapy. This is a rare opportunity to define how life‑changing science becomes real‑world medicine.
Primary Responsibilities
Build, lead, and scale the marketing and launch planning function; manage budget, resources, vendor/agency relationships, and KPIs tied to demand generation and launch readiness
Develop and execute integrated brand and launch planning strategies for Lexeo’s cardiac pipeline (initially US-focused and future global expansion)
Shape and evolve Lexeo’s brand story as a leader in genetic cardiovascular medicine, partner with external communications (media, PR, social, thought leadership, IR)
Build deep customer segmentation and personas across key stakeholders: opinion leaders, cardiologists, genetic specialists, patient advocacy groups, and other members of multi‑disciplinary care teams
Lead disease awareness and diagnosis‑activation initiatives in partnership with Medical and Patient Affairs
Define evidence needs and value propositions for payer engagement, pricing, and provider strategies
Contribute to strategic planning and commercial prioritization across the portfolio
Develop messaging frameworks for HCPs, patients, and payers, emphasizing genetic causes, durability, and impact of therapies.
Expand Lexeo commercial infrastructure with an eye toward commercial launches, including data and analytics, field reporting, patient support and commercial intelligence
Serve as the commercial voice on cross‑functional teams, ensuring alignment from early stage through launch
Collaborate with new and growing field teams, including market access, medical affairs, field reimbursement and sales
Required Skills & Qualifications
Bachelor’s in Life Sciences, Marketing, or Business required; MBA, PharmD, or PhD preferred.
10+ years in life sciences marketing or launch planning (rare disease, gene therapy, advanced biologics), with both upstream (strategy, portfolio) and downstream (brand, digital) experience.
Experience in developing launch readiness for novel therapies (cell/gene therapies, biologics in rare/monogenic disease); experience in specialty/high‑science areas is preferred
Strong scientific acumen; familiarity with AAV platforms, manufacturing, and regulatory pathways.
Deep competency in digital/omnichannel marketing: CRM, automation, SEO/SEM, analytics, content strategy.
Strong cross‑functional collaboration skills and ability to influence senior leadership
Ability to translate complex science into compelling commercial narratives
About Lexeo Lexeo Therapeutics is a clinical‑stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact.
Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.
Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.
We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.
Seniority level
Associate
Employment type
Full-time
Job function
Business Development and Sales
Transportation, Logistics, Supply Chain and Storage
Referrals increase your chances of interviewing at Lexeo Therapeutics by 2x
Get notified about new Director Corporate Strategy jobs in
New York, NY .
#J-18808-Ljbffr
Base pay range $220,000.00/yr - $275,000.00/yr
The Senior Director of Corporate Strategy & New Product Planning will play an integral role in bringing our groundbreaking AAV gene therapies to patients with genetic cardiomyopathies. In this high-impact role, the incumbent will build Lexeo’s launch planning function from the ground up, shaping brand strategy, market development, and launch readiness for first-in-class therapies poised to transform care in cardiac genetic diseases with high unmet need. You’ll combine strategic vision with hands‑on execution, crafting compelling scientific narratives, driving disease awareness, and preparing providers, patients, and payers for a new era in gene therapy. This is a rare opportunity to define how life‑changing science becomes real‑world medicine.
Primary Responsibilities
Build, lead, and scale the marketing and launch planning function; manage budget, resources, vendor/agency relationships, and KPIs tied to demand generation and launch readiness
Develop and execute integrated brand and launch planning strategies for Lexeo’s cardiac pipeline (initially US-focused and future global expansion)
Shape and evolve Lexeo’s brand story as a leader in genetic cardiovascular medicine, partner with external communications (media, PR, social, thought leadership, IR)
Build deep customer segmentation and personas across key stakeholders: opinion leaders, cardiologists, genetic specialists, patient advocacy groups, and other members of multi‑disciplinary care teams
Lead disease awareness and diagnosis‑activation initiatives in partnership with Medical and Patient Affairs
Define evidence needs and value propositions for payer engagement, pricing, and provider strategies
Contribute to strategic planning and commercial prioritization across the portfolio
Develop messaging frameworks for HCPs, patients, and payers, emphasizing genetic causes, durability, and impact of therapies.
Expand Lexeo commercial infrastructure with an eye toward commercial launches, including data and analytics, field reporting, patient support and commercial intelligence
Serve as the commercial voice on cross‑functional teams, ensuring alignment from early stage through launch
Collaborate with new and growing field teams, including market access, medical affairs, field reimbursement and sales
Required Skills & Qualifications
Bachelor’s in Life Sciences, Marketing, or Business required; MBA, PharmD, or PhD preferred.
10+ years in life sciences marketing or launch planning (rare disease, gene therapy, advanced biologics), with both upstream (strategy, portfolio) and downstream (brand, digital) experience.
Experience in developing launch readiness for novel therapies (cell/gene therapies, biologics in rare/monogenic disease); experience in specialty/high‑science areas is preferred
Strong scientific acumen; familiarity with AAV platforms, manufacturing, and regulatory pathways.
Deep competency in digital/omnichannel marketing: CRM, automation, SEO/SEM, analytics, content strategy.
Strong cross‑functional collaboration skills and ability to influence senior leadership
Ability to translate complex science into compelling commercial narratives
About Lexeo Lexeo Therapeutics is a clinical‑stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact.
Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.
Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.
We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.
Seniority level
Associate
Employment type
Full-time
Job function
Business Development and Sales
Transportation, Logistics, Supply Chain and Storage
Referrals increase your chances of interviewing at Lexeo Therapeutics by 2x
Get notified about new Director Corporate Strategy jobs in
New York, NY .
#J-18808-Ljbffr